MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm
Sample report - Filter (14041 patents) - PatentInspiration
WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search
WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search
Sample report - Filter (14041 patents) - PatentInspiration
Sample report - Filter (14041 patents) - PatentInspiration
US7547704B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
On the origin of biochemistry at an alkaline hydrothermal vent. - Abstract - Europe PMC
3‐(3‐amino‐3‐carboxypropyl)‐5,6‐Dihydrouridine is one of two novel post‐transcriptional modifications in tRNALys(UUU) from Trypanosoma brucei - Krog - 2011 - The FEBS Journal - Wiley Online Library
US7384924B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm
IJMS | Free Full-Text | The Potential of Metabolomics in the Diagnosis of Thyroid Cancer | HTML
MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm
MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm
Urinary Nucleosides and Deoxynucleosides - ScienceDirect
US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm
US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
US7192936B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
Subcellular relocalization and nuclear redistribution of the RNA methyltransferases TRMT1 and TRMT1L upon neuronal activation
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm
Merging Metal–Nucleobase Chemistry With Supramolecular Chemistry - ScienceDirect
Nucleobase Protection of Deoxyriboâ•' and Ribonucleosides
US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
